Ursula Ravens

Dr. Ursula Ravens


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2004 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
JHJürgen F. Heubach
Jürgen F. Heubach
EGEva M. Graf
Eva M. Graf
JLJudith Leutheuser
Judith Leutheuser
MBManja Bock
Manja Bock
BBBartosz Balana
Bartosz Balana
URUrsula Ravens
Ursula Ravens
Human mesenchymal stem cells (hMSC) have gained considerable interest due to their potential use for cell replacement therapy and tissue engineering. One strategy is to differentiate these bone marrow stem cells in vitro into cardiomyocytes prior to implantation. In this context ion channels can be important functional markers of cardiac differentiation. At present there is little information about the electrophysiological behaviour of the undifferentiated hMSC. We therefore investigated mRNA expression of 26 ion channel subunits using semiquantitative RT‐PCR and recorded transmembrane ion currents with the whole‐cell voltage clamp technique. Bone marrow hMSC were obtained from healthy donors. The cells revealed a distinct pattern of ion channel mRNA with high expression levels for some channel subunits (e.g. Kv4.2, Kv4.3, MaxiK, HCN2, and α1C of the L‐type calcium channel). Outward currents were recorded in almost all cells. The most abundant outward current rapidly activated at potentials positive to +20 mV. This current was identified as a large‐conductance voltage‐ and Ca2+‐activated K+ current, conducted by MaxiK channels, due to its high sensitivity to tetraethylammonium (IC50= 340 μm) and its inhibition by 100 nm iberiotoxin. A large fraction of cells also demonstrated a more slowly activating current at potentials positive to –30 mV. This current was selectively inhibited by clofilium (IC50= 0.8 μm). Ba2+ inward currents, stimulated by 1 μm BayK 8644 were found in a few cells, indicating the expression of functional L‐type Ca2+ channels. Other inward currents such as sodium currents or inward rectifier currents were absent. We conclude that undifferentiated hMSC express a distinct pattern of ion channel mRNA and functional ion channels that might contribute to physiological cell function.

24 July 2008 in EP Europace
Verified
Journal Article
Open access
PDF file
URUrsula Ravens
Ursula Ravens
ECElisabetta Cerbai
Elisabetta Cerbai
Abnormal excitability of myocardial cells may give rise to ectopic beats and initiate re-entry around an anatomical or functional obstacle. As K + currents control the repolarization process of the cardiac action potential (AP), the K + channel function determines membrane potential and refractoriness of the myocardium. Both gain and loss of the K + channel function can lead to arrhythmia. The former because abbreviation of the active potential duration (APD) shortens refractoriness and wave length, and thereby facilitates re-entry and the latter because excessive prolongation of APD may lead to torsades de pointes (TdP) arrhythmia and sudden cardiac death. The pro-arrhythmic consequences of malfunctioning K + channels in ventricular and atrial tissue are discussed in the light of three pathophysiologically relevant aspects: genetic background, drug action, and disease-induced remodelling. In the ventricles, loss-of-function mutations in the genes encoding for K + channels and many drugs (mainly hERG channel blockers) are related to hereditary and acquired long-QT syndrome, respectively, that put individuals at high risk for developing TdP arrhythmias and life-threatening ventricular fibrillation. Similarly, down-regulation of K + channels in heart failure also increases the risk for sudden cardiac death. Mutations and polymorphisms in genes encoding for atrial K + channels can be associated with gain-of-function and shortened, or with loss-of-function and prolonged APs. The block of atrial K + channels becomes a particular therapeutic challenge when trying to ameliorate atrial fibrillation (AF). This arrhythmia has a strong tendency to cause electrical remodelling, which affects many K + channels. Atrial-selective drugs for the treatment of AF without affecting the ventricles could target structures such as IKur or constitutively active IK,ACh channels.

15 December 2010 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
URUrsula Ravens
Ursula Ravens
EWErich Wettwer
Erich Wettwer
The ultrarapid delayed rectifier channels have attracted considerable interest as targets for ‘atrial-selective’ antiarrhythmic drugs because they contribute to atrial but not to ventricular repolarization. Thus, IKur channel blockers are expected to prolong selectively the atrial effective refractory period without inducing proarrhythmic effects due to excessive ventricular action potential prolongation. Here we provide an overview of the properties of IKur channels in expression systems and native cardiomyocytes. The ion conducting pore of the channel is formed by four Kv1.5 α-subunits, whereas the ancillary β-subunits Kvβ1.2, Kvβ1.3, and Kvβ2.1 control channel trafficking and plasma membrane integration as well as activation and inactivation kinetics. Investigation of IKur channel blockers in cardiomyocytes is complicated (i) by substantial overlap of IKur with other currents, notably the transient outward current Ito, (ii) by lack of drug selectivity, and (iii) by disease-induced regulation of IKur. Some new compounds developed as IKur blockers are described and their efficacy in treatment of atrial fibrillation (AF) is discussed. Current evidence suggests that pure IKur channel block may not be sufficient to suppress AF.

1 August 2008 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
TCT Christ
T Christ
EWE Wettwer
E Wettwer
NVN Voigt
N Voigt
OHO Hála
O Hála
SRS Radicke
S Radicke
URUrsula Ravens
Ursula Ravens
Background and purpose: This study was designed to establish the pathology‐specific inhibitory effects of the IKur/Ito/IK,ACh blocker AVE0118 on atrium‐selective channels and its corresponding effects on action potential shape and effective refractory period in patients with chronic AF (cAF).Experimental approach: Outward K+‐currents of right atrial myocytes and action potentials of atrial trabeculae were measured with whole‐cell voltage clamp and microelectrode techniques, respectively. Outward currents were dissected by curve fitting.Key results: Four components of outward K+‐currents and AF‐specific alterations in their properties were identified. Ito was smaller in cAF than in SR, and AVE0118 (10 μM) apparently accelerated its inactivation in both groups without reducing its amplitude. Amplitudes of rapidly and slowly inactivating components of IKur were lower in cAF than in SR. The former was abolished by AVE0118 in both groups, the latter was partially blocked in SR, but not in cAF, even though its inactivation was apparently accelerated in cAF. The large non‐inactivating current component was similar in magnitude in both groups, but decreased by AVE0118 only in SR. AVE0118 strongly suppressed AF‐related constitutively active IK,ACh and prolonged atrial action potential and effective refractory period exclusively in cAF.Conclusions and implications: In atrial myocytes of cAF patients, we detected reduced function of distinct IKur components that possessed decreased component‐specific sensitivity to AVE0118 most likely as a consequence of AF‐induced electrical remodelling. Inhibition of profibrillatory constitutively active IK,ACh may lead to pathology‐specific efficacy of AVE0118 that is likely to contribute to its ability to convert AF into SR.British Journal of Pharmacology (2008) 154, 1619–1630; doi: 10.1038/bjp.2008.209; published online 9 June 2008

22 January 2013 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
EWErich Wettwer
Erich Wettwer
TCTorsten Christ
Torsten Christ
SESebastian Endig
Sebastian Endig
NRNadiia Rozmaritsa
Nadiia Rozmaritsa
KMKlaus Matschke
Klaus Matschke
URUrsula Ravens
Ursula Ravens
Vernakalant is a newly developed antiarrhythmic drug against atrial fibrillation (AF). However, its electrophysiological actions on human myocardium are unknown. Action potentials (APs) and ion currents were recorded in right atrial trabeculae and cardiomyocytes from patients in sinus rhythm (SR) and chronic AF. Vernakalant prolonged early repolarization in SR and AF, but late only in AF. AP amplitude (APA) and dV/dtmax were reduced in a concentration- and frequency-dependent manner with IC50 < 10 µM at >3 Hz. Effective refractory period was increased more than action potential duration (APD) in SR and AF. INa was blocked with IC50s of 95 and 84 µM for SR and AF, respectively (0.5 Hz). Vernakalant did not reduce outward potassium currents compared with time-matched controls. However, area under the current–time curve was reduced due to acceleration of current decline with IC50s of 19 and 12 µM for SR and AF, respectively. Vernakalant had less effect on APD than the IKr blocker E-4031, blocked IK,ACh, and had a small inhibitory effect on IK1 at 30 µM. L-Type Ca2+ currents (SR) were reduced with IC50 of 84 µM. Rate-dependent block of Na+ channels represents the main antiarrhythmic mechanism of vernakalant in the fibrillating atrium. Open channel block of early transient outward currents and IK,ACh could also contribute.

1 May 2003 in Progress in Biophysics and Molecular Biology
Verified
Journal Article
Closed access
URUrsula Ravens
Ursula Ravens